You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 236 No. 14, October 4, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations

V. Gopal, A. L. Bisno and F. J. Silverblatt

In a case of staphylococcal endocarditis, we failed to eradicate Staphylococcus aureus from the blood stream with vancomycin hydrochloride therapy. The strain involved was sensitive to vancomycin by disk diffusion studies but showed a wide disparity between minimal inhibitory and minimal bactericidal concentrations. The lack of a bactericidal effect was probably responsible for the failure of treatment. A synergistic effect was demonstrated for the combination of gentamicin sulfate and methicillin sodium, and the patient was ultimately cured with this combination plus vancomycin. Bactericidal tests are important in choosing an antimicrobial agent for treatment of endocarditis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French
J Antimicrob Chemother 2006;58:1107-1117.
ABSTRACT | FULL TEXT  

Daptomycin Bactericidal Activity and Correlation between Disk and Broth Microdilution Method Results in Testing of Staphylococcus aureus Strains with Decreased Susceptibility to Vancomycin.
Sader et al.
Antimicrob. Agents Chemother. 2006;50:2330-2336.
ABSTRACT | FULL TEXT  

Activity of Glycopeptides against Staphylococcus aureus Infection in a Rabbit Endocarditis Model: MICs Do Not Predict In Vivo Efficacy
Asseray et al.
Antimicrob. Agents Chemother. 2005;49:857-859.
ABSTRACT | FULL TEXT  

Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Sakoulas et al.
J. Clin. Microbiol. 2004;42:2398-2402.
ABSTRACT | FULL TEXT  

Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of Endocarditis
Moore et al.
Antimicrob. Agents Chemother. 2003;47:1262-1266.
ABSTRACT | FULL TEXT  

Combinations of Vancomycin and beta -Lactams Are Synergistic against Staphylococci with Reduced Susceptibilities to Vancomycin
Climo et al.
Antimicrob. Agents Chemother. 1999;43:1747-1753.
ABSTRACT | FULL TEXT  

Bacterial Endocarditis with a Tolerant Staphylococcal Organism
McMillan and Weiner
CLIN PEDIATR 1982;21:252-254.
ABSTRACT  

Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis
Tamer and Bray
CLIN PEDIATR 1982;21:125-126.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.